Podcasts about gynecology

Ep. 396 Twins Untangled: The Data Behind Safe Twin Birth with Dr. Stu In this week's episode of The Birth Lounge Podcast, HeHe sits down with Dr. Stu Fischbein to unpack the truth about twin births, and it's probably not what your provider has told you. They dive into why C-sections have become the default for twins in the U.S. (hint: it's not because it's safer), and how our medical system continues to over-manage what can often be a normal variation of birth. Dr. Stu breaks down what's really happening with rising twin pregnancies, how assisted reproductive technology plays a role, and why evidence still supports vaginal twin births when handled by skilled providers. You'll hear them talk about: How to find a provider who's actually experienced with vaginal twin births The real deal on ECVs, breech twins, and what “mono-mono” and “mono-di” really mean How to advocate for your birth plan even when you're having multiples If you're expecting twins, or just want to understand how broken our twin birth system has become, this episode is your blueprint for making informed, confident choices and protecting your power in the birth room. 00:00 Introduction to Twin Births 01:07 Welcome to The Birth Lounge Podcast 01:14 Black Friday Sale Announcement 02:29 The Birth Lounge Overview 09:52 Special Guest: Dr. Stu Fischbein 10:21 Challenges and Misconceptions About Twin Births 11:25 Dr. Stu's Background and Expertise 12:48 Navigating Twin Births in the Medical System 14:15 The Importance of Informed Consent 15:51 Current Landscape of Twin Births 20:49 Training and Skills in Obstetrics 35:34 Risks and Realities of Twin Births 57:29 Legislation and Training in Midwifery 59:07 Economic Incentives in Birth Practices 01:00:16 Personal Experience with Baby Gear 01:03:31 Cost Analysis of C-Sections vs. Vaginal Births 01:04:50 Hospital Policies and C-Section Rates 01:08:44 Historical Perspective on Birth Practices 01:14:08 Twin Births: Hospital vs. Home 01:20:30 Challenges in Breech Deliveries 01:24:27 External Cephalic Version (ECV) Insights 01:30:42 Timing and Risks in Twin Deliveries 01:40:07 Final Thoughts and Advice for Expecting Mothers   Guest Bio: Stuart J. Fischbein MD is a community-based obstetrician and an Associate of the American College of Obstetrics & Gynecology, published author of the book “Fearless Pregnancy, Wisdom & Reassurance from a Doctor, A Midwife and A Mom” and peer-reviewed papers Homebirth with an Obstetrician, A Series of 135 Out of Hospital Births and Breech birth at home: outcomes of 60 breech and 109 cephalic planned home and birth center births. After completing his residency at Cedars-Sinai Medical Center in Los Angeles, CA, Dr. Stu spent 24 years assisting women with hospital birthing and, for the last 13 years, has been a homebirth obstetrician who works directly with midwives. Since retiring from attending home births in 2022, Dr. Stu has turned his focus to traveling around the world as a lecturer and advocate for reteaching breech & twin birth skills, respect for the normalcy of birth and honoring informed consent. He hosts a weekly podcast with co-host Blyss Young and together they offer hope, reassurance and safe, honest evidence supported choices for those women who understand pregnancy is a normal bodily function not to be feared. Follow him on Instagram @birthinginstincts. His websites are www.birthinginstincts.com & www.birthinginstinctspodcast.com INSTAGRAM: Connect with HeHe on IG  Connect with Dr. Stu on IG    BIRTH EDUCATION: Join The Birth Lounge here for judgment-free childbirth education that prepares you for an informed birth and how to confidently navigate hospital policy to have a trauma-free labor experience!   Download The Birth Lounge App for birth & postpartum prep delivered straight to your phone!   LINKS/RESOURCES MENTIONED: Check out our episode with Dr. Stu's cohost, Blyss Young (ep. 232)    Listen to episode 179 with Dr. Rixa Freeze    Here's a link to the Primitive Reflexes episode Dr. Stu references   https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0313941   www.birthinginstincts.com   https://podcasts.apple.com/us/podcast/birthing-instincts/id1552816683   www.birthinginstinctspodcast.com   https://pubmed.ncbi.nlm.nih.gov/30305050/   https://static1.squarespace.com/static/52ca1028e4b05c5f2d7b157d/t/62e02090874eae67b683bc67/1658855570428/A+Maneuver+for+Head+Entanglement+Published.pdf

On this episode of Transmission Interrupted, host Jill Morgan sits down with Dr. John Horton, Vice Chair of Clinical Affairs for Gynecology and Obstetrics at Emory, to explore one of the most challenging intersections in healthcare: special pathogens and pregnancy. From emerging threats like Ebola and Marburg to familiar concerns like measles and chickenpox, they dive deep into what makes caring for pregnant patients so uniquely complex in the face of infectious diseases.Join us for a candid and insightful conversation on the evolving best practices for labor and delivery in high-risk situations. Dr. Horton shares lessons learned on the front lines, why compassion and humanity matter as much as protocol, and practical advice on infection prevention, disaster drills, and protecting both patients and healthcare workers.Whether you're in obstetrics, infectious disease, emergency preparedness, or just curious about what makes pregnancy and pathogens such a tough clinical challenge, this episode is packed with fresh insights and actionable takeaways.GuestJohn Patrick Horton, MD, MBAVice Chair of Clinical AffairsGynecology and Obstetrics DepartmentEmory UniversityDr. John Horton is the Vice Chair of Clinical Affairs for Emory University's Department of Gynecology and Obstetrics. He also serves as Emory Healthcare's Division Director for General Gynecology and Obstetrics, and Interim Operations Director for the Gynecologic Specialties Division. Additionally, Dr. Horton is the Director of the Obstetric Rapid Response Team at Emory Healthcare and is Associate Professor at the Emory University School of Medicine Department of Gynecology and Obstetrics. HostJill Morgan, RNEmory HealthcareJill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI).ResourcesNETEC:https://netec.orgNETEC Resource Library:https://repository.netecweb.org/NETEC YouTube:https://www.youtube.com/@TheNETECNETEC Newsletter:https://netec.org/newsletter-sign-up/Transmission Interrupted:https://netec.org/podcast/About NETECA Partnership for PreparednessThe National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources.Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems.For more information visit NETEC on the web at www.netec.org.NETEC...

Today we have Dr. Marina Walther-Antonio, a Mayo Clinic researcher who investigates the role of the microbiome in cancer and reproductive health, particularly endometrial and ovarian cancers. According to the World Cancer Research Fund International, endometrial and ovarian cancers are among the top 10 most prevalent cancers in women worldwide, and there are still no standard screenings for early detection. Marina is an assistant professor in the Department of Surgery and the Mayo Clinic Center for Individualized Medicine Microbiome Program. She has a joint appointment in the department of Obstetrics and Gynecology. Today we talk to Marina about how she and her colleagues are utilizing the methodologies of environmental microbiology and technologies used in astrobiology to improve our understanding of endometrial and ovarian cancers. Through her investigations into the microbiome, she and her team are developing early detection tests that will enable clinical interventions before certain cancers develop. Show notes: [00:03:13] Dawn opens our interview asking Marina about the history of her interest in extraterrestrial life. [00:05:49] Dawn mentions that Marina did her undergraduate studies in Portugal at the University of Aveiro, where she majored in biology. Dawn asks why Marina chose biology as her major. [00:06:39] Ken explains that the undergraduate programs at Aveiro University require students to do a year of research outside the university and asks Marina about her experience with this requirement. [00:08:34] Ken explains that while Marina was conducting her internship at NASA Ames Research Center, there were several projects under way at the astrobiology institute, with the one that Marina was assigned to looking at a Mars analogue site in Oregon's Warner Valley. Ken asks what kind of work Marina did on this project. [00:10:06] Ken asks Marina why after earning a master's degree in microbiology from Indiana University, she went to Washington State University to earn a Ph.D. in environmental sciences. [00:13:29] Dawn asks about Marina's Ph.D. research on microbialites, which are microbial structures that can thrive at the bottom of certain freshwater lakes and other extreme environments. [00:16:02] Dawn explains that just as Marina began researching microbial populations, the Mayo Clinic Center for Individualized Medicine created a microbiome program. Dawn asks Marina about the circumstances that led to her joining Mayo. [00:19:05] Dawn mentions that Dr. Claire Fraser, the director of Maryland's Institute for Genome Sciences pointed out in Episode 32 of STEM-Talk that there are more microbes on a single person's hands than there are people on Earth, as well as the fact that our gut is home to more than 100 trillion bacteria. Dawn asks Marina to talk about this microbial side of humanity. [00:21:51] Ken mentions that if listeners are interested in learning more about the microbiome and how it affects human health, they should listen to Episodes 20 and 168 with Dr. Alessio Fasano. Ken asks Marina to give a short overview of the microbiome. [00:25:37] Dawn asks Marina how the focus of her research shifted to the role of the microbiome in cancer and reproductive health. [00:29:00] Dawn explains that endometrial and ovarian cancers are among the top 10 most prevalent cancers in women worldwide; with ovarian cancer being the most common gynecological malignancy and the fifth leading cause of death due to cancer in women in the nation. Dawn goes on to explain that in a 2023 paper Marina investigated the area of microbiome that is associated with ovarian cancer to better understand the microbiome's potential in early detection. Dawn asks Marina to talk about this study and its findings. [00:35:55] Given the small scale and sample size of her initial study, Ken asks Marina what her ideal follow-up study would look like. [00:38:37] Ken mentions that in 2019 Marina published the r...

Stillbirths are far more common than previously believed, according to a new study just published in the Journal of the American Medical Association. Dr. Bob Silver, Chairman of the Department of Obstetrics and Gynecology at the University of Utah, joins to talk about the new findings on pregnancy and stillbirth risks, and what families need to know.

Taking folic acid prior to conception and during pregnancy can help protect the unborn baby from developing abnormalities. Supplements are particularly important for women who have epilepsy, as anti-seizure medication (previously known as anti-convulsants or anti-epileptic drugs) can lead to a deficiency in folic acid. Until 2023, high doses of 4-5 mg per day were recommended. However, this has changed as the data has changed. Did you know the SMFM no longer recommends “high dose” folic acid preconceptionally for patients on seizure medications? This is also highlighted in a recently released epub from Obstetrics and Gynecology (Green Journal) on October 31, 2025. Listen in for details. 1. Mokashi, Mugdha MD, MPH; Cozzi-Glaser, Gabriella MD; Kominiarek, Michelle A. MD, MS. Dietary Supplements in the Perinatal Period. Obstetrics & Gynecology ():10.1097/AOG.0000000000006098, October 31, 2025. | DOI: 10.1097/AOG.00000000000060982. Asadi-Pooya AA. High dose folic acid supplementation in women with epilepsy: are we sure it is safe? Seizure. 2015 Apr;27:51-3. doi: 10.1016/j.seizure.2015.02.030. Epub 2015 Mar 7. PMID: 25891927.3. https://aesnet.org/about/aes-press-room/press-releases/guideline-issued-for-people-with-epilepsy-who-may-become-pregnant4. Turner C, McIntosh T, Gaffney D, Germaine M, Hogan J, O'Higgins A. A 10-year review of periconceptual folic acid supplementation in women with epilepsy taking antiseizure medications. J Matern Fetal Neonatal Med. 2025 Dec;38(1):2524094. doi: 10.1080/14767058.2025.2524094. Epub 2025 Jun 30. PMID: 40588438.5. https://www.aan.com/PressRoom/Home/PressRelease/5170#:~:text=The%20guideline%20recommends%20that%20people,and%20possibly%20improve%20neurodevelopmental%20outcomes.6. https://aesnet.org/about/aes-press-room/press-releases/guideline-issued-for-people-with-epilepsy-who-may-become-pregnant

Dealing with menopause symptoms is rough enough, but navigating a cancer diagnosis at the same time causes even more stress and anxiety.  As a holistic-focused physician going through menopause, a diagnosis of breast cancer put a bump in the road for Dr. Suzanne Gilberg-Lenz, leading to concerns about how she would navigate her own journey.  It can be hard to feel heard by your physician, and advocating for things like holistic healing options, lab testing, and hormone replacement therapy can become an endless battle. But as a women's empowerment advocate and a public educator, Dr. Suzanne is here today to help YOU advocate for your needs and to speak up about your situation because you deserve to be heard.  Hearing Dr. Suzanne's story can help you get through any tough times you're facing. Especially for the breast cancer community– there are ways you can manage your longevity and your health now going forward for the better. Check out this podcast to find out how!  Suzanne Gilberg-Lenz, MD  Dr. Suzanne Gilberg-Lenz earned her medical degree from the USC School of Medicine and completed her residency in Obstetrics and Gynecology at UCLA/Cedars-Sinai Medical Center. She frequently appears as an expert in women's health and integrative medicine in print, online, and on TV, where she's the Chief Medical Correspondent for the Drew Barrymore Show. She's the author of MENOPAUSE BOOTCAMP: Optimize Your Health, Empower Your Self, and Flourish as You Age.  IN THIS EPISODE Dr. Suzanne's perimenopause and menopause journey  Opening up about a breast cancer diagnosis Recognizing symptoms of perimenopause vs. other health issues  Non-negotiables for women's health in our 40s and beyond  Hormone therapy options in midlife  Advocating for yourself with your primary physician  Adaptogenic herbs that are helpful in midlife  Stress, sleep, and cardiometabolic tips for optimal health  Grassroots and community building via the Menopause Bootcamp Facilitator Certification  RESOURCES MENTIONEDUse code ENERGIZED and get $100 off on your CAROL Bike purchase https://carolbike.pxf.io/GK3LaE Menopause Bootcamp Certification Course  Get 20% off with Code: Energized20 Get Dr. Suzanne's book HERE: Menopause Bootcamp  Dr. Suzanne's Website Dr. Suzanne's Socials:  Facebook Instagram  TikTok YouTube  RELATED EPISODES  #590: Dispelling Myths About Breast Cancer And Mammograms + Navigating Hrt After Breast Cancer With Dr. Jenn Simmons 579: Hormone Replacement Options And Hormone Testing For Women In Midlife + Self Advocacy For Optimal Health With Esther Blum #547: What You Need To Know About The Opill And Hormone Changes In Perimenopause With Dr. Carrie Jones #404: Do Women Need To Wait Till Menopause To Begin Hormone Replacement Therapy? With Esther Blum

Elinzanetant, sold under the brand name Lynkuet, receivedapproval from the U.S. Food and Drug Administration (FDA) on October 24, 2025, for the treatment of moderate to severe hot flashes due to menopause.  How is this different than Fezolinetant, which was approved in 2023? Listen in for details. 1.   Menegaz de Almeida, Artur MS; Oliveira, Paloma MS; Lopes, Lucca MD; Leite, Marianna MS; Morbach, Victória MS; Alves Kelly, Francinny MD; Barros, Ítalo MS; Aquino de Moraes, Francisco Cezar MS; Prevedello, Alexandra MD. Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-analysis. Obstetrics & Gynecology 145(3):p 253-261, March 2025. | DOI: 10.1097/AOG.00000000000058122.     Pinkerton JV, Simon JA, Joffe H, Maki PM, NappiRE, Panay N, Soares CN, Thurston RC, Caetano C, Haberland C, Haseli Mashhadi N, Krahn U, Mellinger U, Parke S, Seitz C, Zuurman L. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials. JAMA. 2024 Aug 22;332(16):1343–54. doi: 10.1001/jama.2024.14618. Epub ahead of print. PMID: 39172446; PMCID: PMC11342219.3.     Cardoso F, Parke S, Brennan DJ, Briggs P,Donders G, Panay N, Haseli-Mashhadi N, Block M, Caetano C, Francuski M, Haberland C, Laapas K, Seitz C, Zuurman L. Elinzanetant for Vasomotor Symptomsfrom Endocrine Therapy for Breast Cancer. N Engl J Med. 2025 Aug 21;393(8):753-763. doi: 10.1056/NEJMoa2415566. Epub 2025 Jun 2. PMID: 40454634.STRONG COFFEE PROMO: 20% Off Strong CoffeeCompany https://strongcoffeecompany.com/discount/CHAPANOSPINOBG

Ever wondered what it's like to train and practice obstetrics and gynecology across New Zealand and Australia? In this episode of BackTable OBGYN, Dr. Amy Park sits down with Dr. Michael Wynn-Williams, a renowned gynecologist and endometriosis specialist. Dr. Wynn-Williams discusses his extensive training across New Zealand, Australia, the UK, and Scotland, emphasizing his role in minimally invasive gynecology.---SYNPOSISThe conversation covers the nuances of gynecology and obstetrics training in Australia and New Zealand, the balance between public and private healthcare systems, and the cultural differences in medical practice. Dr. Wynn-Williams also sheds light on issues like medical-legal environments, insurance, the impact of geography on healthcare delivery, and the integration of advanced ultrasound practices in endometriosis care. The episode provides valuable insights for those considering a career in gynecology in these regions.---TIMESTAMPS00:00 - Introduction07:35 - Training in Australia and New Zealand15:05 - Public and Private Healthcare Systems20:25 - Challenges and Equity in Healthcare24:39 - Balancing Public and Private Practice28:48 - Inpatient Services and Day Case Hysterectomy29:46 - City vs. Rural Practices and Equity Issues31:55 - Staffing Challenges in New Zealand33:57 - Living and Working in New Zealand and Australia35:25 - Navigating Medical Practice Transfers40:10 - Medical-Legal Environment in Australia and New Zealand43:31 - Gender-Based Reimbursement and Training Challenges51:41 - Endometriosis Ultrasound Scanning and Collaboration52:27 - Final Thoughts---RESOURCESThe Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), the professional body responsible for training, accreditation, and standards in obstetrics and gynecology in both countrieshttps://ranzcog.edu.au/

We challenge the band-aid approach to women's midlife health and show how faith and functional medicine uncover root causes behind hormones, fatigue, and heavy periods. We separate myth from evidence on HRT and give clear first steps to advocate for lasting change.• why conventional gynecology misses upstream causes• burnout, back pain, and a pivot to functional medicine• the mindset shift from insurance-driven fixes to real healing• heavy periods, IUD risks, and synthetic progestin concerns• functional medicine's timeline and root-cause method• estrogen versus progestins and WHI study context• safer, bioidentical HRT paired with lifestyle repair• practical first steps to self-advocacy and hope• inviting God into the healing journeyCHECK OUT THE ENTIRE MIDLIFE RESET SUMMIT!! https://midliferesetsummit.com/Did you know over 6,000 women enter menopause every single day in the U.S. ? The medical system isn't helping them heal at the root — and that's where faith-based coaches come in.

On January 18, 2020, we released an episode called “Vaginal Vit C for BV? Yep, it's DATA”. That was 5 years ago! Now, in the Green Journal, a new systematic review and meta-analysis is examining this subject….AGAIN. Plus, this is not the only systematic review to investigate this; a similar review was published in Acta Obstétrica e Ginecológica Portuguesa earlier this year (2025) in March. So, did we get it right 5 years ago? Can vaginal Vit C help in eliminating BV? Listen in for details!1. Khaikin, Yannay MD; Elangainesan, Praniya MD, MSc; Winkler, Eliot MD, MSc; Liu, Kuan PhD, MMath; Selk, Amanda MD, MSc; Yudin, Mark H. MD, MSc. Intravaginal Vitamin C for the Treatment and Prevention of Bacterial Vaginosis: A Systematic Review and Meta-analysis. Obstetrics & Gynecology ():10.1097/AOG.0000000000006092, October 23, 2025. | DOI: 10.1097/AOG.0000000000006092; https://journals.lww.com/greenjournal/pages/articleviewer.aspx?year=9900&issue=00000&article=01389&type=Fulltext2. Acta Obstétrica e Ginecológica Portuguesa (March 2025): chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://scielo.pt/pdf/aogp/v19n1/1646-5830-aogp-19-01-40.pdf3. Chapa Clinical pearls 2020: https://podcasts.apple.com/gh/podcast/vaginal-vit-c-for-bv-yep-its-data/id1412385746?i=1000463002444

OBGYN Doctor Lenora Williams of UConn Obstetrics and Gynecology discusses menopause! What are the symptoms, the treatments and the myths? Dr. Williams has all the answers and the positive outlook!

Welcome to Fertility & Sterility Roundtable! Each month, we will host a discussion with the authors of "Views and Reviews" and "Fertile Battle" articles published in a recent issue of Fertility & Sterility. This month, we welcome Dr. Brian Levine and Dr. Kate Schoyer to discuss if physicians should be facilitating gestational carrier arrangements in the absence of a medical indication, also known as elective surrogacy. Dr. Brian Levine is the founding partner and practice director of CCRM New York, where he has helped countless families on their path to parenthood. Dr. Levine is also the founder of Nodal, the premier online gestational surrogacy platform, which connects intended parents and surrogates in a trusted and transparent way. Dr. Kate Schoyer is an Associate Professor of Obstetrics and Gynecology and Reproductive Endocrinology and Infertility at the Medical College of Wisconsin. She is the Director of the Division of Reproductive Endocrinology and Infertility and is the Medical Director of the Reproductive Medicine Center at Froedtert Hospital. Her research interests include factors contributing to success with ART, the impact of BMI, and therapies for patients with diminished ovarian reserve. View Fertility and Sterility at https://www.fertstert.org/

October 24, 2025 In episode 264 of the Urology Coding and Reimbursement Podcast, Scott and Mark Painter sit down with Ken Mitchell, PA-C, a nationally recognized expert in men's health and a champion for advanced practice providers (APPs) in urology. Ken shares insights on the growing urology workforce shortage, the evolving role of APPs, and recent payer challenges—like restrictions on APP-administered Xiaflex in Arkansas. He also introduces his nonprofit, Gynecology, which promotes men's health education and training. This episode is a must-listen for practices navigating workforce limitations, payer pushback, and the future of urologic care.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

The health benefits of breastfeeding for infants are already well established. However, researchers at the Peter MacCallum Cancer Centre have recently published a study showing that pregnancy and breastfeeding can also help protect against breast cancer. Dr. Nisha Khot, Clinical Director of Obstetrics and Gynecology at Peninsula Health, explains how this research could help reduce breast cancer rates among Australian women.

I was recently asked to OPINE on the labor management for a patient who was receiving IV Pitocin for augmentation, who experienced a placental abruption. One physician stated that in "his opinion", Pitocin increased the risk of placental abruption intrapartum, a point which the original treating physician refuted. So, I was asked to be the "referee" on the play. IV Pitocin can result in some maternal-fetal complications but is abruption one of them as a stand-alone complication. Was the first reviewer's opinion correct? Listen in for details.1. Ben-Aroya Z, Yochai D, Silberstein T, Friger M, Hallak M, Katz M, Mazor M. Oxytocin use in grand-multiparous patients: safety and complications. J Matern Fetal Med. 2001 Oct;10(5):328-31. doi: 10.1080/714904358. PMID: 11730496.2. Morikawa M, Cho K, Yamada T, et al. Do Uterotonic Drugs Increase Risk of Abruptio Placentae and Eclampsia? Archives of Gynecology and Obstetrics. 2014;289(5):987-91. doi:10.1007/s00404-013-3101-8.3. ACOG: First and Second Stage Labor Management: ACOG Clinical Practice Guideline No. 8. Obstetrics and Gynecology. 2024;143(1):144-162. doi:10.1097/AOG.0000000000005447.4. Pitocin. FDA Drug Label. Food and Drug Administration Updated date: 2024-08-125. Litorp H, Sunny AK, Kc A. Augmentation of Labor With Oxytocin and Its Association With Delivery Outcomes: A Large-Scale Cohort Study in 12 Public Hospitals in Nepal.Acta Obstetricia Et Gynecologica Scandinavica. 2021;100(4):684-693. doi:10.1111/aogs.13919.

About this episode: Prescribing medicine to address fever or pain in pregnancy is a delicate task with a need to consider both potential benefits and risks. In this episode: Obstetrician Dr. Angie Jelin shares how she discusses Tylenol use with expectant parents in the context of emerging evidence and recent news from the federal government. Guests: Dr. Angie Jelin is the assistant director of prenatal genetics at the Prenatal Diagnostic Center in the Division of Maternal-Fetal Medicine and an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Autism Risk Linked to Fever During Pregnancy—Columbia Mailman School of Public Health Interpreting the Data on Tylenol, Pregnancy, and Autism—Public Health On Call (September 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Current guidelines recommend universal collection of a vaginal-rectal swab for GBS colonization at 36-37 weeks and 6 days for the identification of patients who require intrapartum IV antibiotic coverage to prevent early onset neonatal GBS infection/sepsis. Recently, we had a patient in clinic whose GBS culture at 36 weeks was negative. Good right? Well, the patient was on amoxicillin at the time for pharyngitis. Did that course of oral PCN based therapy affect the GBS culture result? Should we believe that culture or could it be a false negative, demanding rescreen after therapy completion? There is currently a GAP here in the guidance. In this episode we will cover this controversial scenario, look at the data, and provide a real-world implementable approach to this case.1. Kim DD, Page SM, McKenna DS, Kim CM. Neonatal Group B Streptococcus Sepsis After Negative Screen in a Patient Taking Oral Antibiotics. Obstetrics and Gynecology. 2005;105(5 Pt 2):1259-61. doi:10.1097/01.AOG.0000159040.51773.bf.2. ACOG CO Number 797 (Replaces Committee Opinion No. 782, June 2019.); 20203. Mackay G, House MD, Bloch E, Wolfberg AJ. A GBS culture collected shortly after GBS prophylaxis may be inaccurate. J Matern Fetal Neonatal Med. 2012 Jun;25(6):736-8. doi: 10.3109/14767058.2011.596961. Epub 2011 Aug 1. PMID: 21801141.STRONG COFFEE PROMO: 20% Off Strong Coffee Company https://strongcoffeecompany.com/discount/CHAPANOSPINOBG

On March 7, 2025, we released an episode summarizing key aspects of a NEJM publication regarding male partner therapy for women with recurrent BV. Although that study had limitations, the results were very surprising. Now, on 10/16/25 (7 months later), the ACOG has a new Clinical Practice Update (CPU) on this very issue. In this episode we will briefly summarize that March 2025 NEJM publication and highlight the TWO updated clinical recommendations from the ACOG regarding male partner therapy for the prevention of BV in women. PLUS, we will briefly discuss why although male partner therapy should be considered, partner EPT is “not recommended” at this time by the ACOG. 1. ACOG CLINICAL PRACTICE UPDATE: Concurrent Sexual Partner Therapy to Prevent Bacterial Vaginosis Recurrence Obstetrics & Gynecology ():10.1097/AOG.0000000000006102, October 16, 2025. | DOI: 10.1097/AOG.00000000000061022. Chapa Clinical Pearls March 2025 Episode: https://open.spotify.com/episode/4sW9tTe9CdYVQsCRBjqQQP3. Vodstrcil LA, Plummer EL, Fairley CK, Hocking JS, Law MG, Petoumenos K, et al. Male-partner treatment to prevent recurrence of bacterial vaginosis. N Engl J Med 2025;392:947–57. doi: 10.1056/NEJMoa2405404STRONG COFFEE PROMO: 20% Off Strong Coffee Company https://strongcoffeecompany.com/discount/CHAPANOSPINOBG

Have you heard of LDN or Low Dose Naltrexone? It's gaining popularity after several studies revealed its support for reproductive health issues like PMS, PMDD, endometriosis, and infertility. Today's episode with NaProTechnology trained nurse midwife, Ashley Jensen, discusses what it is, why it's effective, how it works, and whether you should ask your doctor about it for your own use. She also discusses common side effects, other benefits outside of the reproductive realm, and other options you can try before LDN or other medications. This episode discusses: what LDN ishow LDN works and what makes it effective who it may benefit the most what conditions it affects (reproductive and other) possible side effects and considerationsalternatives to LDN useNOTE: This episode is appropriate for all audiences, but does reference PTSD.GUEST BIO: Ashley J. Jensen, CNM is a certified nurse-midwife who specializes in restorative reproductive medicine to support women experiencing infertility, recurrent miscarriage, and a wide range of women's health concerns, without the use of artificial hormones. She has advanced training in NaProTechnology, FEMM, and Chart Neo, and is passionate about providing holistic, root-cause-based care for conditions such as polycystic ovarian syndrome (PCOS), endometriosis, premenstrual syndrome (PMS), natural family planning, and menopause. Ashley is currently part of the women's health team at the University of Utah. To learn more or view her profile, visit https://healthcare.utah.edu/find-a-doctor/ashley-jensen.HELPFUL LINKS:Ep. 117: Client Story - Ashley (Overcoming PMDD)Ep. 10: Endometriosis 101Dr. Phil Boyle talking about PMS and LDN on YouTubeSend us a textSupport the showOther great ways to connect with Woven Natural Fertility Care: Learn the Creighton Model System with us! Register here! Get our monthly newsletter: Get the updates! Chat about issues of fertility + faith: Substack Follow us on Instagram: @wovenfertility Watch our episodes on YouTube: @wovenfertility Love the content? The biggest gift you could give is to click a 5 star review and write why it was so meaningful! This podcast is provided for educational and informational purposes only and does not constitute providing medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. Neither Woven nor its staff, nor any contributor to this podcast, makes any represe...

Host: Jasmine T. Kency, M.D., Associate Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.Topic(s): This is a special "Drive Time" episode with segments from previous episodes on Potential Pregnancy Complications, Mental Health Month, Ear Nose and Throat, and Metabolic Syndrome Part II. Guest(s): Elizabeth Lutz, M.D., Associate Professor of Medicine in the Department of Obstetrics and Gynecology at UMMC.Rakesh K. Chandra, M.D., Professor in the Department of Otolaryngology at the University of Mississippi Medical CenterDyelicia Vasquez, Licensed Clinical Social Worker at Therapeutic EvolutionsDr. Danny Riche, Clinical Pharmacist at the University of Mississippi Medical CenterEmail the show: remedy@mpbonline.org.If you enjoy listening to this podcast, please consider contributing to MPB. https://donate.mpbfoundation.org/mspb/podcast. Hosted on Acast. See acast.com/privacy for more information.

A New Podcast from Obstetrics & Gynecology, featuring members from the Editorial Team and contributing authors, each month as they highlight the latest research and practice updates in the field. This episode features an interview with Dr. Shant Apelian, author of “Uterine Transposition for Fertility Preservation and Ovarian Conservation in Patients Undergoing Pelvic Radiotherapy.”

A New Podcast from Obstetrics & Gynecology, featuring members from the Editorial Team and contributing authors, each month as they highlight the latest research and practice updates in the field. This episode features an interview with Drs. Lauren Caldwell and Shunaha Kim-Fine, authors of “Standardized Counseling Tool for Returning to Sexual Activity After Pelvic Reconstructive Surgery” and “Intervention Counseling for Return to Sex After Urogynecologic Surgery: A Randomized Controlled Trial.”

Podcast family, as we have said on many previous occasions, we get episode suggestions from either real-world patient encounters, from things that are hot in press, and/or from podcasts family member suggestions. Recently, one of our podcast family members asked me about the utility ofperforming pelvic floor muscle therapy (PFMT) antepartum. Is this evidence-based? Does performing PFMT help with postpartum urinary incontinence? Not all PFMTs are Kegel exercises! In this episode, we will review peripartum urinary incontinence and answer the question, “Is there value in teaching antepartum PFMT?”. We will summarize key concepts from the Oct 2025 Narrative Review on thissubject from the Green Journal (Obstet Gynecol).1.     Siddique, Moiuri MD, MPH; Hickman, Lisa MD;Giugale, Lauren MD. Peripartum Urinary Incontinence and Overactive Bladder.Obstetrics & Gynecology 146(4):p 466-472, October 2025. | DOI:10.1097/AOG.00000000000059932.     Woodley SJ, Lawrenson P, Boyle R, et al. PelvicFloor Muscle Training for Preventing and Treating Urinary and Faecal Incontinence in Antenatal and Postnatal Women. The Cochrane Database of SystematicReviews. 2020;5:CD007471. doi:10.1002/14651858.CD007471.pub4.3.     Pelvic Floor Muscle Training to Prevent andTreat Urinary and Fecal Incontinence in Antenatal and Postnatal Patients. AmericanAcademy of Family Physicians (2021). Practice Guideline STRONG COFFEE PROMO: 20% Off Strong CoffeeCompany https://strongcoffeecompany.com/discount/CHAPANOSPINOBG

There is very little in the practice of holistic health that has escaped the attention of Dr. Christiane Northrup over the past quarter-century. Christiane has experienced the huge highs as a highly successful New York Times best-selling author and a favorite of many (including Oprah Winfrey) to the dark days of COVID when her once-coveted advice was censored and ignored.Fortunately, none of the recent pushback has silenced Dr. Christiane Northrup who describes a plandemic gone bad and all of the problems associated with women's health, including the misuse of synthetic hormones, this week on Spirit Gym.Learn more about the asset-based sharing system for gold and silver ownership that Paul and Dr. Northrup talked about here.Learn more about Christiane and her work on her website and her product line for hormonal balance at Amata Life. Find her on social media via Truth Social, Facebook, Twitter/X, YouTube, Rumble, Instagram and Telegram along with Substack. Download her free Should You Try Herbs to Support the Change ebook at this link.Timestamps9:22 Christiane's decision to go to medical school was based partly on how the established medical system was failing her family.12:12 Focusing on obstetrics and gynecology and being with pregnant women was what Christiane was designed by God to do.20:54 Many bodily problems women suffer from are their way of expressing their distress.30:03 Why do women living in the Western world suffer from so many bad symptoms associated with menopause?46:35 “If you did things to animals that we do to humans [at birth], the mother would reject the cubs.”1:04:03 How the chapter of John in the Bible fits well with the message of The Matrix Trilogy.1:15:59 Christiane's take on the countless ways so many handled/orchestrated COVID so very badly.ResourcesFind  all resources for this episode on our website.Music Credit: Meet Your Heroes (444Hz), Composed, mixed, mastered and produced by Michael RB Schwartz of Brave Bear MusicThanks to our awesome sponsors:PaleovalleyBIOptimizers US and BIOptimizers UK PAUL15Organifi CHEK20Wild PasturesKorrect SPIRITGYMPique LifeCHEK Institute/CHEK AcademyPaul's Dream Interpretation workshop We may earn commissions from qualifying purchases using affiliate links.

In the 09/1/2018 Society for Academic Specialists in General Obstetrics and Gynecology's (SASGOG's) Pearls of Exxcellence publication, “Management of Preeclampsia at Term”, it states: “If hypertension management requires acute IV treatment, it is often prudent to initiate oral labetalol or EXTENDED-release nifedipine to maintain blood pressures below the severe range. Intrapartum blood pressure management and consultation should not delay progress towards delivery. Fetal monitoring should be continuous.” In the original ACOG CO 692 from 2017, oral nifedipine was first referenced as an alternative to IV meds GIVEN INTRAPARTUM, stating, “Although relatively less information currently exists for the use of calcium channel blockers for this clinical indication, the available evidence suggests that immediate release oral nifedipine also may be considered as a first-line therapy, particularly when intravenous access is not available.” This may be given orally as 10mg, 20mg, and 20 mg separated in time by 20 minutes per dose. Notice it says “immediate release oral nifedipine”. But what about EXTENDED release nifedipine intrapartum as stated by the SASGOG? Is that an option after immediate attentive and therapy has been given with IV anti-hypertensives? Listen in for details.1. Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period: Committee Opinion, Number 692. Obstetrics & Gynecology 129(4):p e90-e95, April 2017. | DOI: 10.1097/AOG.00000000000020192. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020 Jun;135(6):e237-e260. doi: 10.1097/AOG.0000000000003891. PMID: 32443079.3. Cleary EM, Racchi NW, Patton KG, Kudrimoti M, Costantine MM, Rood KM. Trial of Intrapartum Extended-Release Nifedipine to Prevent Severe Hypertension Among Pregnant Individuals With Preeclampsia With Severe Features. Hypertension. 2023 Feb;80(2):335-342. doi: 10.1161/HYPERTENSIONAHA.122.19751. Epub 2022 Oct 3. PMID: 36189646.STRONG COFFEE PROMO: 20% Off Strong Coffee Company ⁠https://strongcoffeecompany.com/discount/CHAPANOSPINOBG

No money, no mission. Understanding coding is the key to funding care and making your practice sustainable. In this episode of BackTable OBGYN, host, Dr. Mark Hoffman, chats with Dr. Jon Hathaway, associate professor at IU School of Medicine and coding specialist. They discuss the intricacies of medical billing, the impact of coding knowledge on revenue, and the systemic gaps in residency training regarding financial literacy. ---SYNPOSISDr. Hathaway shares his journey from mastering coding to becoming a national expert, providing a crash course on CPT, RVU, and ICD codes, and emphasizing the importance of accurate billing for the sustainability of healthcare practices. The episode offers valuable insights into the challenges and opportunities in medical coding and the broader financial aspects of healthcare.---TIMESTAMPS00:00 - Introduction 02:03 - Dr. Hathaway's Journey into Coding04:11 - Understanding the Financial Side of Healthcare07:10 - The Disconnect in Healthcare Payments11:26 - The Complexity of Medical Billing18:11 - The Role of CPT, RVU, and ICD Codes24:03 - The Process of Approving New Procedures32:38 - Understanding the Value Update Process33:47 - Case Study: Cystoscopy in Hysterectomy Codes35:26 - Survey Participation and Its Impact36:12 - Roles and Responsibilities in ACOG38:12 - Challenges of RVU-Based Compensation42:08 - Specialty-Specific RVU Valuation48:42 - Comparing OB and GYN Reimbursements50:02 - Envisioning an Ideal Healthcare System55:10 - Maximizing Billing Efficiency59:46 - Final Thoughts

Episode SummaryThe FDA held a rare public hearing to reconsider the safety labels on vaginal estrogen—a pivotal moment for menopause care.In this episode, Dr. James Simon, a leading menopause specialist and clinical researcher, joins Georgie Kovacs to unpack what the hearing revealed, why the current labeling may do more harm than good, and what it means for millions of women experiencing genitourinary syndrome of menopause (GSM), recurrent UTIs, painful sex, and incontinence.Together, they explore how outdated warnings, lack of education, and systemic biases continue to shape women's access to treatment—and what both women and clinicians need to know as change finally takes shape.Discussion PointsWhy is the FDA reconsidering the vaginal estrogen warning label now?What does genitourinary syndrome of menopause (GSM) actually mean—and how common is it?How do current black box warnings limit women's access to safe and effective therapies?What's the real risk of vaginal estrogen and breast cancer—and what does the evidence say?How can updated labeling improve care for UTIs, painful sex, and incontinence?What steps can clinicians take to confidently prescribe vaginal estrogen?What role does the media and misinformation play in perpetuating fear around menopause care?How can women advocate for themselves if their doctor is hesitant to prescribe?What's next for the FDA—and how could this hearing reshape menopause treatment in the U.S.?

In today's episode, leading experts across oncology specialties previewed the key studies and data they are most anticipating ahead of the 2025 ESMO Congress. Dana M. Chase, MD, a professor of Clinical Obstetrics and Gynecology in the Division of Gynecologic Oncology at UCLA, discussed her excitement to see findings from a phase 1 trial (NCT05403554) investigating NI-1801 in patients with heavily pretreated, mesothelin-expressing platinum-resistant epithelial ovarian cancer. Premal H. Thaker, MD, MS, the David G. and Lynn Mutch Distinguished Professor of Obstetrics and Gynecology and director of Gynecologic Oncology Clinical Research at Siteman Cancer Center in Saint Louis, Missouri, discussed the anticipation for findings from a multi-omic analysis of the phase 3 AtTEnd/ENGOT-EN7 trial (NCT03603184) of atezolizumab in patients with endometrial cancer and data demonstrating that the WES-derived Aneuploidy Score may identify patients with mismatch repair–deficient endometrial cancer who derive reduced benefit from immunotherapy. Zev Wainberg, MD, the Estelle, Abe, and Marjorie Sanders Chair in Cancer Research at UCLA, shared his anticipation for new data in gastrointestinal oncology, particularly the overall survival results from the phase 3 MATTERHORN trial (NCT04592913) of durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel in patients with resectable gastric and gastroesophageal cancer, which are expected to provide pivotal updates following previously reported event-free survival outcomes. Sagus Sampath, MD, an associate clinical professor and medical director of the Department of Radiation Oncology at City of Hope in Duarte, California, highlighted the phase 2 NorthStar trial (NCT03410043) evaluating osimertinib (Tagrisso) with or without local consolidative therapy in patients with metastatic EGFR-mutated non–small cell lung cancer (NSCLC).

In this episode, Ali speaks with Dr. James A. Simon, a leading OB-GYN and "Menopause Whisperer," about his pioneering work in sexual medicine and menopause care. Dr. Simon discusses the challenges and importance of addressing sexual health in gynecology, the evolution of hormone therapy, and the cultural barriers that often prevent open conversations about menopause and women's sexuality.The episode highlights the need for more holistic, individualized care for women, the impact of hormones on health and wellbeing, and the progress still needed in medical education and societal attitudes. Listeners will come away with a deeper understanding of menopause, hormone therapy, and the value of compassionate, open dialogue about women's health and aging.Topics also include how aging has changed over generations, why people got scared of Hormone Replacement Therapy, the prevalence and benefits of testosterone in women, the politics of hysterectomies, how Viagra was happened upon, and how GLP-1s work. FOR MORE ALI MEZEY:ALI - WebsiteALI - LinkTreeFOR MORE JAMES:IntimMedicine Website: https://intimmedicine.com/YouTube: https://www.youtube.com/@intimmedicinespecialists5815/videosFacebook: https://www.facebook.com/IntimMedicineRestore Yourself: A Woman's Guide to Reviving Her Sexual Desire and Passion for LifeBook by Dr. James A. Simon.JAMES BIO:James A. Simon, MD, CCD, MSCP, IF, FACOGDr. James A. Simon is a board-certified Ob/Gyn, and reproductive endocrinologist. He is Clinical Professor of Obstetrics and Gynecology at The George Washington University School of Medicine in Washington, DC. Dr. Simon also holds certifications as an AASECT-Certified Sexuality Counsellor, an ISCD-Certified Clinical Bone Densitometrist, and a Menopause Society-Certified menopause specialist. He has an active private practice, IntimMedicine Specialists® in Washington, DC focused on complicated gynecology, sexual medicine for both men and women, and menopause. Dr. Simon has received numerous awards including: “Top Washington Physicians,” “America's Top Obstetricians and Gynecologists,” “Super Doctors of Washington DC-Baltimore-Northern Virginia,” and “The Best Doctors in America.” He is the only physician to serve as President of both The Menopause Society and the International Society for the Study of Women's Sexual Health. Nicknamed “The Menopause Whisperer,” by Washingtonian Magazine, Dr. Simon is an established researcher and author--completing more than 450 research trials, and more than 800 published articles, abstracts, chapters, and the paperback book: Restore Yourself: A Woman's Guide to Reviving Her Sexual Desire and Passion for Life. Dr. Simon loves riding the best rollercoasters in the world, collecting fountain pens and wristwatches, and freshwater fishing. He is a five-time Master Angler of Canada.hiker, dog trainer, and lover of nature.OTHER RESOURCES, LINKS AND INSPIRATIONS: ASECT (American Association of Sexuality Educators, Counselors and Therapists)A professional organization for sexuality educators, counselors, and therapists.ISCD (International Society for Clinical Densitometry)Organization focused on bone density and skeletal health.Menopause SocietyFormerly known as the North American Menopause Society (NAMS), dedicated to promoting the health and quality of life of women through an understanding of menopause.International Society for the Study of Women's Sexual Health (ISSWSH)Multidisciplinary, academic, and scientific organization dedicated to women's sexual health.Washingtonian Magazine ArticleRegional magazine that dubbed Dr. Simon "The Menopause Whisperer."Sexual Health AllianceOrganization and conference for sexual health professionals.Women's Health Initiative Hormone StudiesLandmark studies on hormone therapy in women.Menopause MeetingsAnnual conferences for menopause specialists.PremarinEstrogen medication derived from pregnant mares' urine, historically used in hormone therapy.Viagra (Sildenafil)Medication for erectile dysfunction, originally developed for high blood pressure.GLP-1 Receptor AgonistsClass of injectable medications for diabetes and weight loss (e.g., Ozempic, Wegovy).Dr. Dympna RenshawSouth African psychiatrist and pioneer in sexual medicine, especially in the context of trauma and dysfunction.Halle Berry, Kate WinsletCelebrities mentioned for their advocacy and openness about menopause.Contraception Marches (late 1960s)Historical reference to activism for access to contraception.[From time to time, a word or phrase goes wonky. Please forgive my wandering wifi.]

A micropastics expert and a UC San Francisco Professor of Obstetrics and Gynecology and Reproductive Sciences, Dr. Tracey Woodruff, joins Amy & JJ to explain microplastics, why we are worried about them and what to do to decrease our exposure. See omnystudio.com/listener for privacy information.

In this episode of the Born Wild Podcast, host Sophia Henderson speaks with Dr. Stuart Fischbein, an obstetrician with decades of experience advocating for physiological birth, midwifery collaboration, and informed consent. Dr. Stu shares his journey from medical student to outspoken advocate for respectful maternity care.They discuss the importance of understanding the risks associated with various birth methods — including breech births and VBACs — and emphasize the need for individualized care in obstetrics. This conversation shines light on the challenges within the maternity care system and the importance of trusting women's bodies during childbirth.⸻What You'll Learn: • How Dr. Stu's journey into obstetrics began unexpectedly • Why informed consent is often misunderstood in the medical system • The importance of midwives in supporting physiological birth • Why VBAC should be viewed as a standard variation of normal birth • How “high risk” is often defined by provider comfort rather than evidence • The decline of breech and twin birth skills — and why they matter • The dangers of profit-driven maternity care • How to rebuild trust in nature's design for birth⸻Guest Bio:Stuart J. Fischbein, MD is a community-based obstetrician and an Associate of the American College of Obstetrics & Gynecology. He is the author of Fearless Pregnancy, Wisdom & Reassurance from a Doctor, A Midwife, and A Mom and several peer-reviewed papers including Homebirth with an Obstetrician, Breech Birth at Home, and Twin Home Birth: Outcomes of 100 Sets of Twins in the Care of a Single Practitioner.After completing his residency at Cedars-Sinai Medical Center in Los Angeles, Dr. Stu spent 24 years assisting women with hospital births before transitioning to homebirth obstetrics for over 12 years. Since retiring from attending births in 2022, he has focused on teaching and advocacy — traveling internationally to reteach breech and twin birth skills, promote respect for physiological birth, and uphold informed consent.He co-hosts the Birthing Instincts Podcast with Blyss Young, offering hope, reassurance, and evidence-based guidance to families who understand that pregnancy is a normal, healthy function — not a medical condition to be feared.

Menopause is a significant phase in a woman's life, yet it is often surrounded by misconceptions and misinformation. Join our conversation with Dr. Karen Adams, Clinical Professor of Obstetrics and Gynecology at Stanford University, as she unpacks the complexities of menopause and hormone therapy. Discover the impact of the Women's Health Initiative and how it shaped the conversation around hormone use, leading to a dramatic decline in its adoption. Dr. Adams will also address common myths, explore effective non-hormonal treatment options, and share insights on managing symptoms through lifestyle changes. This discussion will provide you with practical tools and a deeper understanding of menopause, helping to demystify this important life transition. Read Transcript: https://mcdn.podbean.com/mf/web/tv5a6jejhjre5pru/medcast_episode111.pdf CME Information: https://stanford.cloud-cme.com/medcastepisode111 Claim CE and MOC: https://stanford.cloud-cme.com/Form.aspx?FormID=3582  

In this episode of the Optimal Body Podcast, Dr. Jen and Dr. Dom are joined by fertility expert Dr. Natalie Crawford. They dive into a thorough discussion on women's health, focusing on fertility, menstrual health, and preparing for pregnancy. Dr. Crawford explains the menstrual cycle, addresses common misconceptions, and highlights the importance of self-advocacy, stress management, and lifestyle for women's health and reproductive health. She also shares insights from her upcoming book, "The Fertility Formula," empowering listeners with practical advice for optimizing fertility and navigating women's health challenges like infertility and pregnancy loss.VivoBarefoot Discount:Support your feet and ankles with VivoBarefoot shoes—with perfect styles for any occasion! Boost foot health through mobility and strength from the ground up. Use code OPTIMAL20 for 20% off. 100-day trial included—return if you're not satisfied!Needed Discount:Jen trusted Needed Supplements for fertility, pregnancy, and beyond! Support men and women's health with vitamins, Omega-3, and more. Used by 6,000+ pros. Use code OPTIMAL for 20% off at checkout!Dr Crawford's Resources:Dr Crawford on IGDr Crawford's YoutubeDr Crawford's WebsiteDr Crawford's TikTokWe think you'll love:Pelvic Floor FoundationsJen's InstagramDom's InstagramYouTube ChannelWhat You'll Learn From Dr Crawford:05:11 Discussion on why fertility is an important indicator of overall health and longevity.09:36 Dr. Crawford explains the phases, hormones, and normal function of the menstrual cycle.14:28 Clarifies normal and abnormal pain, bleeding, and ovulatory symptoms during the menstrual cycle.20:09 Explores how birth control is used to mask symptoms...For full show notes and resources visit https://jen.health/podcast/429 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send me a text! I'd LOVE to hear your feedback on this episode!Dr. Bruce Dorr is certified by the American Board of Obstetrics and Gynecology in OB/Gyn and Female Pelvic Medicine and Reconstructive Surgery.  He is a member of the American Urogynecology Society and the American Association of Gynecological Laparoscopy.  He became certified as a Biote medical practitioner in 2015 and provides hormone optimization with pellet therapy for both men and women. Dr. Bruce Dorr is the Senior Medical Advisor for Biote.We dig into menopause timing, BRCA risk, HRT choices, and why estrogen isn't the simple villain it's made out to be. Dr. Bruce Dorr helps us distinguish between real cancer risk and fear, and map practical steps that protect both lifespan and day-to-day well-being.• redefining perimenopause symptoms and timelines• how progesterone loss disrupts sleep, mood, and cycles• heavy bleeding, iron deficiency, and thyroid slowdown links• toxins, stress, and insulin resistance as hormone disruptors• BRCA risk, modern gene panels, and smarter screening• estrogen metabolism pathways and detox support• ovarian cancer risk and timing of oophorectomy• prophylactic mastectomy tradeoffs and monitoring• bioidentical vs synthetic: receptors, delivery, and risk• oral vs transdermal estrogen safety differences• pellets pros and cons: compliance vs flexibility• HRT after cancer: options, limits, and quality of life• building a personalized plan with labs and follow-upBe sure to follow my show, rate it, review it, and share itSend me an email, sandy at sandyknutrition.caFollow me on all my social media channels. It's Sandy Knutrition everywhereShare this episode with another beauty who would benefit from hearing the wisdom that Dr. Bruce Doer shares with usSupport the showPlease rate & review my podcast with a few kind words on Apple or Spotify. Subscribe wherever you listen, share this episode with a friend, and follow me below. This truly gives back & helps me keep bringing amazing guests & topics every week.Instagram: https://www.instagram.com/sandyknutrition/Facebook Page: https://www.facebook.com/sandyknutritionTikTok: https://www.tiktok.com/@sandyknutritionYouTube: https://www.youtube.com/channel/UCIh48ov-SgbSUXsVeLL2qAgRumble: https://rumble.com/c/c-5461001Linkedin: https://www.linkedin.com/in/sandyknutrition/Substack: https://sandykruse.substack.com/Podcast Website: https://sandykruse.ca

In July 2023, the ACOG released a Practice Advisory stating, “Based on data on the benefit of adjunct HPV vaccination, ACOG recommends adherence to the current Centers for Disease Control and Prevention (CDC) recommendations for vaccinations of individuals aged 9–26 years, and to consider adjuvant HPV vaccination for immunocompetent previously unvaccinated people aged 27–45 years who are undergoing treatment for CIN 2+”. The possible beneficial effect of peri-treatment HPV vaccination goes back to the early 2010s. But science is always changing, and MEDICINE MOVES FAST. In September 2025, the Lancet's Obstetrics, Gynecology, and Women's Health journal published the VACCIN trial to test that guidance. These authors found that, “Although previous studies, including meta-analyses and observational studies, have shown that adjuvant HPV vaccination reduces the recurrence of cervical dysplasia after surgical treatment, our trial suggests that adjuvant HPV vaccination is not effective in reducing the recurrence of CIN 2–3 lesions, contradicting the conclusions of previous works”. They have also called for a REVISION to prior guidance. This is FASCINATING. Listen in for details. 1. ACOG PA July 2023, “Adjuvant Human Papillomavirus Vaccination for Patients Undergoing Treatment for Cervical Intraepithelial Neoplasia 2+”2. Adjuvant prophylactic human papillomavirus vaccination for prevention of recurrent high-grade cervical intraepithelial neoplasia lesions in women undergoing lesion surgical treatment (VACCIN): a multicentre, phase 4 randomised placebo-controlled trial in the Netherlands: https://www.sciencedirect.com/science/article/pii/S305050382500007X#:~:text=To%20our%20knowledge%2C%20this%20is,the%20conclusions%20of%20previous%20works.STRONG COFFEE PROMO: 20% Off Strong Coffee Company https://strongcoffeecompany.com/discount/CHAPANOSPINOBG

Women make up half the population, but their rights have always been treated like a special request. In this episode we dive into the real history of women's rights in America: from forced sterilizations and credit card restrictions to the myth of the 19th Amendment being a universal win. We exposes how progress has always come with an asterisk and why women's rights are the ultimate test of any democracy.The Original Setup: Eve, the Apple, and the Birth of BlameVotes for Some: The Long Road to Women's SuffrageRights on Paper, Fights in Practice: A Tour Through Women's HistoryThe Mother of Gynecology - and the Daughters Who Paid the PriceSterilized and Silenced: When Reproductive Rights Were't Yours'Til Regret Do us Part: Marriage, Divorce and the Trap of ForeverMusic by Loghan LongoriaFollow us on instagram: Sergio Novoa My Limited View PodResources & ReferencesThe Bible & Eve• Augustine, On the Good of Marriage — Early church writings framing women as morally weaker.• Tertullian, On the Apparel of Women — One of the first texts blaming Eve for humanity's downfall.Women's Suffrage• National Archives: 19th Amendment to the U.S. Constitution• Library of Congress: Frederick Douglass's support at Seneca Falls, 1848.• Alexander Keyssar, The Right to Vote: The Contested History of Democracy in the United States.Voting Rights & Racial Exclusion• U.S. Department of Justice: Voting Rights Act of 1965• Indian Citizenship Act of 1924 (National Archives).• Mae Ngai, Impossible Subjects: Illegal Aliens and the Making of Modern America.Workplace & Economic Rights• U.S. Equal Employment Opportunity Commission: Equal Pay Act of 1963• U.S. Department of Labor: Civil Rights Act Title VII• U.S. Department of Education: Title IX Overview• Federal Reserve: History of the Equal Credit Opportunity Act• Congressional Research Service: Women's Business Ownership Act of 1988.Reproductive Rights• Supreme Court: Roe v. Wade (1973).• Congressional Record: The Hyde Amendment (1976).• Supreme Court: Dobbs v. Jackson Women's Health Organization (2022).Medicine & Exploitation• Harriet A. Washington, Medical Apartheid.• Journal of Medical Ethics: Reproductive Surgery and the Enslaved Body: The Case of J. Marion Sims.Forced Sterilization• Supreme Court: Buck v. Bell (1927).• Paul Lombardo, Three Generations, No Imbeciles.• Dorothy Roberts, Killing the Black Body.• Alexandra Minna Stern, Eugenic Nation.• Madrigal v. Quilligan case (Los Angeles, 1978).• Jane Lawrence, “The Indian Health Service and the Sterilization of Native American Women,” American Indian Quarterly (2000).Marriage, Divorce & Domestic Rights• California Family Law Act of 1969 — first no-fault divorce law.• Andrew Cherlin, Marriage, Divorce, Remarriage.• U.S. Department of Justice: Violence Against Women Act of 1994.

Did you know that C-Section birth is referenced in Shakespeare's Macbeth? Cesarean Section is the most common laparotomy in the world, and yest we are still learning surprising facts about it. This episode we will summarize 2publications which have recently been released. One is from the American Journal of Perinatology (September 2025 ) and the other is from the AJOG (August 2025 ). Does a primary C-section on a laboring uterus have a different risk of PAS in the subsequent pregnancy compared to a non-labored uterus? And what is the percentage of patients who experience “pain” at time of C-section? Listen in for the surprising data.1. Kashani Ligumsky L, Lopian M, Jeong A, Desmond A, Elmalech A, Many A, Martinez G, Krakow D, Afshar Y. Impact of Labor in Primary Cesarean Delivery on Subsequent Risk of Placenta Accreta. Am J Perinatol. 2025 Sep 16. doi: 10.1055/a-2693-8599. Epub ahead of print. PMID: 40957594.2. Somerstein, Rachel. I feel pain, not pressure: a personal and methodological reflection on pain during cesarean delivery. American Journal of Obstetrics & Gynecology, Volume 0, Issue 0 (EPub Ahead of Print)

Welcome to Fertility & Sterility Roundtable! Each month, we will host a discussion with the authors of "Views and Reviews" and "Fertile Battle" articles published in a recent issue of Fertility & Sterility.  This month, we welcome Dr. Lydia Hughes and Dr. Eric Widra to discuss the ethics of egg-sharing, or "split-cycles" for fertility preservation. This is where an egg donor freezes their eggs for their own future use for reduced or no cost in exchange for donating a portion of the cohort. Dr. Hughes is a second-year REI fellow at Northwestern University in Chicago, where she also completed her residency in Obstetrics and Gynecology. She earned her medical degree from the University of Alabama at Birmingham. Dr. Hughes's clinical and academic interests include reproductive ethics, PCOS, and ovarian aging.  Dr. Widra currently serves as Executive Senior Medical officer and Vice President, Development for Shady Grove Fertility and US Fertility, respectively.  He was formerly Chief Medical Officer of SG Fertility, and Associate Director of the Combined Federal Fellowship in Reproductive Endocrinology and Infertility, operated through the NIH, Walter Reed National Military Medical Center and SG Fertility. View Fertility and Sterility at https://www.fertstert.org/    

In this episode of The Future Conceived we begin a new series, Alternative Careers in Reproductive Biology, which explores jobs for reproductive biologist outside of academia. Dr. Victor Ruthig from the University of Colorado Anschutz Medical Campus interviews Dr. Eglė Ortega about Dr. Ortega's non-academic career as a reproductive biologist. Dr. Ortega is a Senior Embryologist on the In Vitro Fertilization team in Advanced Reproductive Medicine & Gynecology at the Fertility Institute of Hawaii.

Just today in clinic, we had a patient, who was well into her third trimester, come to her regular scheduled appointment with new onset left-sided facial droop. Yeah, that's concerning! A complete history and physical was performed and the diagnosis was made of Bell's palsy. This is not a rare event and it can be extremely stressful for the affected mother to be because everybody knows facial droop is not normal! And we have recent data regarding this. In July 2025 in the Journal of Plastic, Reconstructive, and Aesthetic Surgery, authors confirmed that Bell's palsy can have real negative functional and psychosocial implications for those affected. So, in this episode, we are going to discuss Bell's palsy in pregnancy. How do we differentiate this from the more serious differential, which is a stroke? What about treatment? Listen in for details. 1. Wesley, Shaun R. MD; Vates, G. Edward MD, PhD; Thornburg, Loralei L. MD. Neurologic Emergencies in Pregnancy. Obstetrics & Gynecology 144(1):p 25-39, July 2024. | DOI: 10.1097/AOG.00000000000055752. Vrabec JT, Isaacson B, Van Hook JW. Bell's Palsy and Pregnancy.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 2007;137(6):858-61. doi:10.1016/j.otohns.2007.09.009.3. Evangelista V, Gooding MS, Pereira L.Bell's Palsy in Pregnancy.Obstetrical & Gynecological Survey. 2019;74(11):674-678. doi:10.1097/OGX.00000000000007324. JPRAS (July 2025): https://www.jprasurg.com/article/S1748-6815(25)00328-6/fulltextSTRONG COFFEE PROMO: 20% Off Strong Coffee Company https://strongcoffeecompany.com/discount/CHAPANOSPINOBG

Maternal morbidity refers to any complications or health problems that occur during pregnancy or childbirth. And despite incredible advancements in health sciences, severe maternal morbidity is on the rise locally, especially among Black women.According to Common Ground Health, the rate of severe maternal morbidity for mothers who are Black, non-Latina in Monroe County increased over 50 percent in the last decade. Out of 10,000 deliveries, 151 mothers experienced life-threatening complications.A group of local leaders has been meeting regularly to try and address the issue of maternal morbidity.WXXI's health, equity, and community reporter, Racquel Stephen, sat down with two of those leaders to discuss what's causing this issue, and what they are doing to improve outcomes for moms.Our guests for the hour: Tracy Webber, director of the Midwifery Division at University of Rochester Medical Center Eva Pressman, Henry A. Thiede Professor and Chair of the Department of Obstetrics and Gynecology at University of Rochester Medical Center ---Connections is supported by listeners like you. Head to our donation page to become a WXXI member today, support the show, and help us close the gap created by the rescission of federal funding.---Connections airs every weekday from noon-2 p.m. Join the conversation with questions or comments by phone at 1-844-295-TALK (8255) or 585-263-9994, email, Facebook or Twitter. Connections is also livestreamed on the WXXI News YouTube channel each day. You can watch live or access previous episodes here.---Do you have a story that needs to be shared? Pitch your story to Connections.

A New Podcast from Obstetrics & Gynecology, featuring members from the Editorial Team and contributing authors, each month as they highlight the latest research and practice updates in the field. This episode features an interview with Dr. Moiuri Siddique, author of “Peripartum Urinary Incontinence and Overactive Bladder.”

In this eye-opening episode, I explain why conventional period advice is outdated, dismissive, and flat-out wrong for high-achieving women like YOU. You'll learn: ✔️ The 3 lies most women are told about their period ✔️ Why birth control is NOT a fix for hormone chaos ✔️ What your period is actually trying to tell you ✔️ How to start a hormone rhythm reset Whether you're struggling with cramps, mood swings, or mid-cycle crashes — this episode will shift how you see your cycle forever. Vitality Health Rx: Daily Greens powder & Optimal Probiotic – https://shopvrx.com/collections/all-products Use code: FEELGREAT15 for 15% off your first order.  

Maternal perception of decreased fetal movement at term occurs in up to 15% of pregnancies and is a cause for maternal and provider concern. All maternal concerns of decreased fetal movement require an assessment of fetal wellbeing. But what about the patient with recurrent episodes of reduced fetal movements at term? Routine induction of labor is not supported solely for decreased fetal movement in a non-growth-restricted fetus, as increased intervention rates (including induction of labor and early term birth) have not demonstrated improved perinatal outcomes and may increase neonatal morbidity, such as respiratory distress and NICU admission. Some international sources (ISUOG) have recognized the cerebroplacental ratio (CPR) as a possible ultrasound tool to investigate possible early placental insufficiency before fetal growth restriction occurs. Is CPR helpful for decreased fetal movements at term? A new publication from the Lancet's new journal- Obstetrcis, Gynecology, and Women's Health- states that it is. Is the CPR ultrasound assessment recognized by the ACOG or SMFM? Listen in for details. 1. The cerebroplacental ratio: a useful marker but should it be a screening test? (2025): https://obgyn.onlinelibrary.wiley.com/doi/10.1002/uog.29154#:~:text=The%20ISUOG%20guidelines%20recommend%20using,after%2038%20weeks'%20gestation44.2. Turner JM, Flenady V, Ellwood D, Coory M, Kumar S.Evaluation of Pregnancy Outcomes Among Women With Decreased Fetal Movements.JAMA logoJAMA Network Open. 2021;4(4):e215071. doi:10.1001/jamanetworkopen.2021.5071.3. Cerebroplacental ratio-based management versus care as usual in non-small-for-gestational-age fetuses at term with maternal perceived reduced fetal movements (CEPRA): a multicentre, cluster-randomised controlled trial. https://www.sciencedirect.com/science/article/pii/S30505038250000204. Hofmeyr GJ, Novikova N. Management of Reported Decreased Fetal Movements for Improving Pregnancy Outcomes. The Cochrane Database of Systematic Reviews. 2012;(4):CD009148. doi:10.1002/14651858.CD009148.pub2.STRONG COFFEE PROMO: 20% Off Strong Coffee Company https://strongcoffeecompany.com/discount/CHAPANOSPINOBG

On this week's episode we talk to Gretchen Sisson, a sociologist studying abortion and adoption. Sisson's research on mothers who choose to relinquish their rights into private adoptions led to her writing Relinquished: The Politics of Adoption and the Privilege of American Motherhood. We talked about that research, her book, and what both experiences have led her to believe about the framework and very existence of adoption in America. Gretchen Sisson is a qualitative sociologist studying abortion and adoption at Advancing New Standards in Reproductive Health in the Department of Obstetrics, Gynecology, and Reproductive Sciences at University of California, San Francisco.Reading RoomRelinquished, by Gretchen Sissonhttps://www.relinquishedbook.com/Since Dobbs, Idaho mothers increasingly accused of child abuse while pregnanthttps://imprintnews.org/child-welfare-2/since-dobbs-idaho-mothers-increasingly-accused-of-child-abuse-while-pregnant/255965A Misguided Rush to Judgment on How Abortion Laws Impact Foster Care https://imprintnews.org/opinion/a-misguided-rush-to-judgment-on-how-abortion-laws-impact-foster-care/256024What Happens When Foster Youth Want an Abortion — and What Could Soon Change?https://imprintnews.org/foster-care/foster-youth-abortion-sabino/66760Roe v. Wade: Unintended Consequenceshttps://imprintnews.org/youth-voice/roe-v-wade-unintended-consequences/66554Overturned Supreme Court Rulings Affect Foster Youth, Toohttps://imprintnews.org/youth-voice/overturned-supreme-court-rulings-affect-foster-youth-too/234958

In 2023, we released 2 episodes on obstructive sleep apnea (OSA) and adverse pregnancy. Now, on September 16, 2025, a new publication from JAMA Network Open adds more insights to disturbed sleep and adverse pregnancy outcomes. How does insomnia affect pregnancy? And is there any data on night shift work and its altered circadian rhythms on adverse pregnancy outcomes? Listen in for details. 1. Ross N, Baer RJ, Oltman SP, et al. Ischemic Placental Disease and Severe Morbidity in Pregnant Patients With Sleep Disorders. JAMA Netw Open. 2025;8(9):e2532189. doi:10.1001/jamanetworkopen.2025.321892. Cai C, Vandermeer B, Khurana R, et al. The Impact of Occupational Shift Work and Working hours during Pregnancy on Health Outcomes: a systematic Review and Meta-Analysis.American Journal of Obstetrics and Gynecology. 2019;221(6):563-576. doi:10.1016/j.ajog.2019.06.051.3. Dominguez JE, Cantrell S, Habib AS, Izci-Balserak B, Lockhart E, Louis JM, Miskovic A, Nadler JW, Nagappa M, O'Brien LM, Won C, Bourjeily G. Society of Anesthesia and Sleep Medicine and the Society for Obstetric Anesthesia and Perinatology Consensus Guideline on the Screening, Diagnosis, and Treatment of Obstructive Sleep Apnea in Pregnancy. Obstet Gynecol. 2023 Aug 1;142(2):403-423. doi: 10.1097/AOG.0000000000005261. Epub 2023 Jul 5. PMID: 37411038; PMCID: PMC10351908.4. Kader M, Bigert C, Andersson T, et al . Shift and Night Work During Pregnancy and Preterm Birth-a Cohort Study of Swedish Health Care Employees. International Journal of Epidemiology. 2022;50(6):1864-1874. doi:10.1093/ije/dyab135.STRONG COFFEE PROMO: 20% Off Strong Coffee Companyhttps://strongcoffeecompany.com/discount/CHAPANOSPINOBG

Brain-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels originate from the cardiac cells in response to cardiac strain. This may come from a pulmonary embolus, an acute severe infection (sepsis), or cardiomyopathy. But what is the relationship between these 2 cardiac biomarkers and preeclampsia? Can preeclampsia with severe features result in an abnormal rise in these 2 proteins exclusive to heart failure. Listen in to this real case scenario which our on call team cared for. 1. Serum Levels of N-Terminal Pro-Brain Natriuretic Peptide in Gestational Hypertension, Mild Preeclampsia, and Severe Preeclampsia: A Study From a Center in Zhejiang Province, China. Zheng Z, Lin X, Cheng X. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2022;28:e934285. doi:10.12659/MSM.934285.2.Evaluation of B-Type Natriuretic Peptide (BNP) Levels in Normal and Preeclamptic Women. Resnik JL, Hong C, Resnik R, et al. American Journal of Obstetrics and Gynecology. 2005;193(2):450-4. doi:10.1016/j.ajog.2004.12.006.3.Increased B-Type Natriuretic Peptide Levels in Early-Onset Versus Late-Onset Preeclampsia. Szabó G, Molvarec A, Nagy B, Rigó J. Clinical Chemistry and Laboratory Medicine. 2014;52(2):281-8. doi:10.1515/cclm-2013-0307.4. Association of N-Terminal Pro–Brain Natriuretic Peptide Concentration in Early Pregnancy With Development of Hypertensive Disorders of Pregnancy and Future Hypertension.5. Hauspurg A, Marsh DJ, McNeil RB, et al. JAMA logoJAMA Cardiology. 2022;7(3):268-276. doi:10.1001/jamacardio.2021.5617.STRONG COFFEE PROMO: 20% Off Strong Coffee Companyhttps://strongcoffeecompany.com/discount/CHAPANOSPINOBG

On Sept 10, 2023, er released an episode titled, “CS Ut Closure: Decidua or No Decidua?”. We highlighted the importance of AVOIDING the decidua at hysterotomy closure at CS. Now, in Sept 2025, in Obstetrics and Gynecology (the Green Journal), there is a new systematic review and meta-analysis on this very topic. Does this new study CONFIRM or REFUTE what we explained 2 years ago? Listen in for details. 1. Sept 10, 2023 Chapa Clinical Pearls Podcast: CS Ut Closure: Decidua or No Decidua?2. Lino GM, Galvão PVM, da Silva MLF, Conrado GAM. Not Closing Compared With Closing the Endometrial Layer During Cesarean Delivery: A Systematic Review and Meta-analysis. Obstet Gynecol. 2025 Jun 12;146(3):e55-e63. doi: 10.1097/AOG.0000000000005974. PMID: 40505112.

We have a wonderful podacst community! Within 24 hours of our immediate past episode release, one close friend- and fellow OBGYN, Dr. Eric Colton (OB Hospitalist Group) reached out and shared valuable words of wisdom regarding a potentially deadly complication of the CS-scar defect...the CS scar ectopic pregnancy. Listen in for Dr. Colton's cameo and details. 1. Ban, Yanli MD, PhD; Shen, Jia MD; Wang, Xia MD; Zhang, Teng MD, PhD; Lu, Xuxu MD; Qu, Wenjie MD; Hao, Yiping MD; Mao, Zhonghao MD; Li, Shizhen MD; Tao, Guowei MD, PhD; Wang, Fang MD, PhD; Zhao, Ying MD, PhD; Zhang, Xiaolei MD, PhD; Zhang, Yuan MD, PhD; Zhang, Guiyu MD, PhD; Cui, Baoxia MD, PhD. Cesarean Scar Ectopic Pregnancy Clinical Classification System With Recommended Surgical Strategy. Obstetrics & Gynecology 141(5):p 927-936, May 2023. | DOI: 10.1097/AOG.0000000000005113

What if the very foundation of America was built on a system that was never meant to serve us all? And what if reclaiming something as simple and as profound as our intuition could be the key to creating a more just and loving future? In this episode of HEAL with Kelly Podcast, I sit down with scholar, advocate, and bestselling author Anna Malaika Tubbs to explore the roots of American patriarchy. Drawing from her recent book Erased: What American Patriarchy Has Hidden from Us and her celebrated debut The Three Mothers, Anna reveals how patriarchy was intentionally written into law, how it continues to shape institutions like healthcare and education, and why reclaiming women's intuition is one of the most radical steps we can take toward change. We explore the intentional design of patriarchy in America's laws, and why recognizing that history is often written by those in power is essential to collective healing. Anna highlights the stories of courageous women who have been erased, yet whose contributions have powerfully shaped our nation's evolution. Anna also shares insights on partnership, motherhood, and the ways our relationships and communities can model new ways of sharing power…the path to true democracy. This conversation is both eye-opening and empowering, offering a reminder that because these systems were built, we have the power to build something different. Key Moments You'll Love: